The professor describes a landscape where medicine no longer treats the patient as a battlefield to be carpet-bombed, but as an ecosystem to be balanced. Her research focuses on immunotherapy—a method that trains white blood cells to recognize the subtle, deceptive signatures of a tumor. It is a quiet revolution of bespoke oncology, where the unique genetic script of a single individual dictates the cure, sparing the body the scorched-earth effects of traditional treatments.
This shift toward precision was echoed by Dr. Suzette Delaloge, who tracks the earliest whispers of malignancy, and Professor Alain Toledano. At the Institut Rafael, Toledano’s team looks past the tumor to the person left behind, offering a sanctuary of integrative medicine that treats the soul and the metabolism with equal gravity.
The discussion turned to the role of artificial intelligence, which researcher Gabriel Malouf described not as a replacement for human judgment, but as a subordinate tool. The machine may process the data, but the physician’s gaze remains the final arbiter of care. This clinical intuition, rooted in the observation of the living person, remains the foundation upon which these new technologies are built.
The historian Stanis Pérez reminded the gathered scientists that the "human dimension" is the only element of medicine that cannot be outsourced to a digital mind. As the Prix Jean Valade was presented, the significance of the evening became clear: the award mandates a direct therapeutic application. It is a prize for the bedside, ensuring that the elegant theories discussed under the dome find their way into the blood and bone of the patients waiting in the wards of the Salpêtrière.